Skip to content Skip to footer
Danyelza: Benefits, Reviews, Info, Side Effects!
Rx Details
Danyelza
Naxitamab-gqgk
Naxitamab
Prescription
Antibody
Drugs
Prescription Only
neuroblastoma treatment, GD2-positive tumors targeting, monoclonal antibody therapy, potential for improved survival rates, pediatric cancer treatment option
Cough, Decreased Appetite, Diarrhea, Dizziness, Fatigue, Fever, Headache, Hypertension, Increased Liver Enzymes, Infusion-Related Reactions, Nausea, Pain, Rash, Vomiting
Danyelza (naxitamab-gqgk) is a monoclonal antibody used in the treatment of certain types of cancer, specifically high-risk neuroblastoma in pediatric patients. The typical dosage regimen for Danyelza involves administering it in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF). The recommended dose of Danyelza is 3 mg/kg/day, given as an intravenous infusion on days 1, 3, and 5 of each treatment cycle. Each cycle is typically repeated every four weeks. However, the exact dosage and schedule may vary based on individual patient factors and the prescribing physician’s judgment. Always consult a healthcare professional for precise dosing information tailored to specific medical conditions.
Neuroblastoma
Safety profile of Danyelza is generally well-tolerated.
No Interactions Reported
$10,000 – $20,000
$17,000

A Synopsis of

Danyelza

Danyelza is a medication that is used in the treatment of neuroblastoma, a type of cancer that commonly affects children. This drug works by targeting a specific protein on the surface of neuroblastoma cells, which helps to slow down the growth and spread of the cancer.

It is important to follow the dosing instructions provided by your healthcare provider when taking Danyelza. This medication is typically given as an intravenous infusion over a period of time, and the frequency of dosing will depend on your individual treatment plan.

Like all medications, Danyelza can cause side effects. Some common side effects may include nausea, vomiting, diarrhea, fatigue, and low blood cell counts. It is important to report any side effects to your healthcare provider so that they can be properly managed.

It is also important to discuss any other medications or supplements you are taking with your healthcare provider before starting Danyelza, as there may be potential interactions that could affect the effectiveness of the medication.

Overall, Danyelza has shown promising results in the treatment of neuroblastoma and has the potential to improve outcomes for patients with this type of cancer. If you have any questions or concerns about Danyelza or your treatment plan, do not hesitate to speak with your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

0
Would love your thoughts, please comment.x
()
x
en_USEN